{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T01:34:27Z","timestamp":1715996067782},"reference-count":24,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2003,9,5]],"date-time":"2003-09-05T00:00:00Z","timestamp":1062720000000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2003,9]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background<\/jats:bold> :\u2002Rectal administration of enemas, foams and suppositories is the most efficient way to deliver locally acting drugs to the distal colon. Ropivacaine, a long\u2010acting local anaesthetic, was chosen as a candidate for a new rectal treatment of ulcerative colitis.<\/jats:p><jats:p><jats:bold>Aim<\/jats:bold> :\u2002To determine the colonic spread of a rectal ropivacaine formulation.<\/jats:p><jats:p><jats:bold>Methods<\/jats:bold> :\u2002In this randomized, incomplete cross\u2010over study, 12 male volunteers were given 200\u2003mg ropivacaine HCl rectally in 20, 40, 60 and 80\u2003mL hydroxypropyl methylcellulose gel. The viscosity of the gel was 1.1\u2003Pa\u2003s. The spread of the radiolabelled (<jats:sup>99m<\/jats:sup>Tc\u2010labelled diethylenetriaminepenta\u2010acetic acid) formulations was assessed by gamma\u2010scintigraphy. Plasma was collected and analysed for ropivacaine base.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold> :\u2002The retrograde spread was limited to the descending colon and the difference between the studied volumes was not statistically significant. Only the 80\u2010mL volume tended to have a larger distribution, although the 20\u2010mL volume showed the same maximal distribution in two subjects. No distinct relationship between volume, retrograde colonic spread and plasma concentrations could be found. Ropivacaine was well tolerated.<\/jats:p><jats:p><jats:bold>Conclusions<\/jats:bold> :\u2002Rectal ropivacaine gel in all volumes between 20 and 80\u2003mL can spread up to the descending colon. There was no relationship between either retrograde colonic spread or the administered volume and the ropivacaine plasma concentrations.<\/jats:p>","DOI":"10.1046\/j.1365-2036.2003.01741.x","type":"journal-article","created":{"date-parts":[[2003,9,12]],"date-time":"2003-09-12T17:42:07Z","timestamp":1063388527000},"page":"655-660","source":"Crossref","is-referenced-by-count":6,"title":["No volume effect on retrograde colonic spread of rectally\u2010administered ropivacaine gel"],"prefix":"10.1111","volume":"18","author":[{"given":"E.","family":"Arlander","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Cederlund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"M\u00e5re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,9,5]]},"reference":[{"key":"e_1_2_12_2_2","first-page":"365","article-title":"New developments in the treatment of inflammatory bowel disease","volume":"0","author":"Mutlu EA","year":"2002","journal-title":"Expert Opinion Inv Drugs"},{"key":"e_1_2_12_3_2","doi-asserted-by":"crossref","unstructured":"BjorckS DahlstromA JohanssonL AhlmanH.Treatment of the mucosa with local anaesthetics in ulcerative colitis.Agents Actions1992: Special no.C60\u201372.","DOI":"10.1007\/BF01991026"},{"key":"e_1_2_12_4_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528909089256"},{"key":"e_1_2_12_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/76.2.300"},{"key":"e_1_2_12_6_2","first-page":"59","article-title":"Ropivacaine inhibits leukocyte rolling, adhesion and CD11b\/CD18 expression","volume":"283","author":"Martinsson T","year":"1997","journal-title":"J Pharm Exp Ther"},{"key":"e_1_2_12_7_2","first-page":"642","article-title":"Beneficial effects of ropivacaine in rat experimental colitis","volume":"291","author":"Martinsson T","year":"1999","journal-title":"J Pharm Exp Ther"},{"key":"e_1_2_12_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s000110050210"},{"key":"e_1_2_12_9_2","first-page":"660","article-title":"Ropivacaine inhibits serum\u2010induced proliferation of colon adenocarcinoma cells in vitro","volume":"288","author":"Martinsson T","year":"1999","journal-title":"J Pharm Exp Ther"},{"key":"e_1_2_12_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1996.tb00179.x"},{"key":"e_1_2_12_11_2","first-page":"263","article-title":"Medical management of ulcerative proctitis, proctosigmoiditis, and left\u2010sided colitis","volume":"12","author":"Bitton A","year":"2001","journal-title":"Semin GI Dis"},{"key":"e_1_2_12_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.02180.x"},{"key":"e_1_2_12_13_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200225080-00003"},{"key":"e_1_2_12_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.00199.x"},{"key":"e_1_2_12_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0953-0673.1996.00327.x"},{"key":"e_1_2_12_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1994.tb00339.x"},{"key":"e_1_2_12_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01296108"},{"key":"e_1_2_12_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006231-198504000-00005"},{"key":"e_1_2_12_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(98)00018-8"},{"key":"e_1_2_12_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.00193.x"},{"key":"e_1_2_12_21_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199120030-00006"},{"key":"e_1_2_12_22_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528209181117"},{"key":"e_1_2_12_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02555391"},{"key":"e_1_2_12_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.00183.x"},{"key":"e_1_2_12_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.01732.x"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2003.01741.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2003.01741.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2003.01741.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T18:16:49Z","timestamp":1697221009000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2003.01741.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["10.1046\/j.1365-2036.2003.01741.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2003.01741.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,9]]}}}